Trial Profile
Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Iguratimod (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Toyama Chemical
- 22 Feb 2018 New trial record